중동 및 북아프리카의 임상시험 인프라 시장 분석 : 지역별

This report provides an overview of the clinical trial infrastructure markets in the Middle East and North Africa (MENA) region. It includes a detailed examination of the market dynamics and an understanding of the MENA clinical trial landscape by study status, phase, type, results and sponsor type.

Report Scope

This report analyzes the Middle East and North Africa (MENA) clinical trial markets, using 2023 as a benchmark year, and offers projections for the forecast period from 2024 to 2029, with estimates of compound annual growth rates (CAGR). The report covers many aspects of the market, including clinical advances, economic factors and business considerations, and outlines the market forces impacting the industry and its phases, study types and therapeutic areas. The report segments the clinical trial market into services, solutions and supplies, and examines the regional dynamics influencing the market.

This report excluded Turkey and Israel from its scope because their clinical trial markets are significantly more advanced than other countries in the MENA region. Including these markets would have skewed the analysis and not accurately reflected the opportunities and challenges the rest of the region faces. This approach ensures a focused examination of MENA's emerging clinical trial landscape, which may be more relevant for companies seeking to expand into less mature markets.

Report Includes

• Analysis of the Middle East and Northern Africa's (MENA) regional markets for clinical trial infrastructure
• Analyses of the market trends, with revenue data for 2023, estimates for 2024, and projected CAGRs through 2029
• Estimate of the current market size and revenue prospects, accompanied by a market share analysis by sponsor type, clinical trial phase, service type, study type, therapeutic area, and country
• An understanding of the opportunities and progressions in clinical trial studies by some select countries in emerging MENA markets
• Facts and figures pertaining to the current market dynamics, advancements in technology, regulations and prospects
• Insights of the ripple effects of the Ukraine-Russia war on clinical trial operations, including supply chain disruptions, regulatory challenges, and patient recruitment and retention
• Analysis of the industry structure, including stakeholders' market shares, clinical trial product/services mapping, and recent key developments

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Reasons for Doing this Study
• Market Summary

Chapter 2 MENA Clinical Trial Industry Outlook

• Global Clinical Trial Market Overview
• MENA Share
• Evolving MENA Clinical Trial Industry
• Infrastructure and Resources: Bridging Gaps in Emerging Markets
• Patient Recruitment Potential: Diverse Populations and High Recruitment Rates
• Cost-Effectiveness
• Regulatory Environment: Harmonization and Local Adaptations
• Government Support and Investments
• Impact of Regional Policies: Incentivizing Clinical Research
• Collaborations Expand Regional Networks
• Emerging Trends: Focus on Precision Medicine and Rare Diseases
• Growing Demand in Oncology and Rare Diseases
• Technological Advances: Digitalizing Clinical Operations
• Understanding the MENA Clinical Trial Landscape

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Regulatory Frameworks Driving Trial Feasibility
• Growing Patient Population Enhancing Recruitment and Diversity
• Technological Advances Streamlining Operations
• Collaborations
• Personalized Medicine Shaping Trial Design
• Market Challenges
• Complex Regulatory Landscape
• Limited Patient Recruitment and Retention
• Insufficient Infrastructure and Site Capacity
• Limited Adoption of Digital Technologies
• Competition for Key Therapeutic Areas
• Market Opportunities
• Regulatory Reforms Enabling Faster Approvals
• Emerging Focus on Oncology and Rare Diseases
• Public-Private Partnerships Boosting Research Capacity
• Focus on Precision Medicine and Genomics

Chapter 4 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis, by Sponsor Type
• Market Analysis, by Phase
• Market Analysis, by Service Type
• Market Analysis, by Study Type
• Market Analysis, by Therapeutic Area

Chapter 5 Emerging Markets

• Egypt
• Overview
• Clinical Trial Landscape Analysis
• Observations
• BCC Recommendations
• Kingdom of Saudi Arabia (KSA)
• Overview
• Clinical Trial Landscape Analysis
• Observations
• BCC Recommendations
• Lebanon
• Overview
• Clinical Trial Landscape Analysis
• Observations
• BCC Recommendations
• United Arab Emirates
• Overview
• Clinical Trial Landscape Analysis
• Observations
• BCC Recommendations
• Iran
• Overview
• Clinical Trial Landscape Analysis
• Observations
• BCC Recommendations

Chapter 6 Russia-Ukraine War Impact Analysis

• Overview
• Supply Chain Disruptions
• Regulatory Challenges
• Patient Recruitment and Retention
• Geopolitical Risks

Chapter 7 Competitive Landscape

• Overview
• Competitive Landscape
• International CROs and Pharmaceutical Companies
• Local CROs and Institutions
• Academic and Research Institutions
• Mapping of Clinical Trial Product Services
• Recent Developments in Clinical Trials in the MENA Region
• Concluding Remarks from BCC

Chapter 8 Appendix

• Methodology
• Research Steps
• Sources
• Abbreviations